급성 세균성 전립선염에서 만성 염증으로의 진행과 관련된 인자의 고찰
Factors of Progression to Chronic Infections from Acute Bacterial Prostatitis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We conducted a retrospective analysis of acute bacterial prostatitis (ABP) to evaluate the factors of progressing to chronic bacterial prostatitis (CBP) and inflammatory chronic pelvic pain syndrome (CPPS) from ABP. Materials and Methods: The clinical records of 480 cases compatible with a confirmed diagnosis of ABP from five urological centers between 2001 and 2010 were reviewed. We defined chronic infection (CI) as a progression to CBP and inflammatory CPPS after treatment of ABP in admission periods when followed-up at 3 months or more. Results were analyzed according to two groups: recovered without CI (group A, n=428) and developed to CI (group B, n=52). Results: Of the 480 ABP patients, 1.3% (6/480) progressed to CBP and 9.6% (46/480) progressed to inflammatory CPPS. The progression rate of CI was 10.9% (52/480). The factors that affected progress to CI were diabetes, prior manipulation, prostate volume, absence of cystostomy and urethral catheterization (p<0.05). Conclusions: The identification and characterization of influential factors may accelerate the development of preventive, diagnostic and therapeutic strategies for the treatment of CI from ABP.
Abstract
Purpose: We conducted a retrospective analysis of acute bacterial prostatitis (ABP) to evaluate the factors of progressing to chronic bacterial prostatitis (CBP) and inflammatory chronic pelvic pain syndrome (CPPS) from ABP. Materials and Methods: The clinical records of 480 cases compatible with a confirmed diagnosis of ABP from five urological centers between 2001 and 2010 were reviewed. We defined chronic infection (CI) as a progression to CBP and inflammatory CPPS after treatment of ABP in admission periods when followed-up at 3 months or more. Results were analyzed according to two groups: recovered without CI (group A, n=428) and developed to CI (group B, n=52). Results: Of the 480 ABP patients, 1.3% (6/480) progressed to CBP and 9.6% (46/480) progressed to inflammatory CPPS. The progression rate of CI was 10.9% (52/480). The factors that affected progress to CI were diabetes, prior manipulation, prostate volume, absence of cystostomy and urethral catheterization (p<0.05). Conclusions: The identification and characterization of influential factors may accelerate the development of preventive, diagnostic and therapeutic strategies for the treatment of CI from ABP.
참고문헌 (18)
- Neal DE Jr, "Acute bacterial prostatitis, in the Textbook of prostatitis. 1st ed", pp.115~121 (1999), Isis Medical Media
- Ludwig M, "Diagnosis and therapy of acute prostatitis, epididymitis and orchitis", Andrologia, 40, pp.76~80 (2008)
- Etienne M, "Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis", BMC Infect Dis, 8, pp.12~21 (2008)
- Naber KG, "EAUguidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)", Eur Urol, 40, pp.576~588 (2001)
- Ha US, "Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 31(1), pp.S96~S101 (2008), Elsevier Science Publishers
- Cho IR, "Clinical Outcome of Acute Bacterial Prostatitis, a Multicenter Study", Korean J Urol, 46, pp.1034~9 (2005)
- Nickel JC, "Changing paradigms for chronic pelvic pain: a report from the chronic pelvic pain", chronic prostatitis scientific workshop, october 19-21, 2005, Baltimore, MD, 2006, pp.통권 : 8, 28~35
- Zhanel GG, "Prevalence of asymptomatic bacteriuria and associated hostfactors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group", Clin Infect Dis, 21, pp.316~322 (1995)
- Geerlings SE, "Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment", Int J Antimicrob Agents, 31(1), pp.54~57 (2008)
- Lindert KA, "Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy", J Urol, 164, pp.76~80 (2000)
- Collins MM, "Prevalence and correlates of prostatitis in the health professionals follow- up study cohort", J Urol, 167, pp.1363~1366 (2002)
- Richardson RD, "Evaluation and management of medically unexplained physical symptoms", Neurologist, 10, pp.18~30 (2004)
- Lee CB, "Does finasteride have a preventive effect on chronic bacterial prostatitis? Pilot study using an animal model", Urologia Internationalis, 86, pp.204~209 (2011)
- Ulleryd P, "Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up", Scand J Infect Dis, 35, pp.34~39 (2003)
- Wagenlehner FM, "Therapy of prostatitis syndrome", Urologe A, 40, pp.24~28 (2001)
- Neal DE Jr, "Treatment of acute prostatitis. In: Textbook of prostatitis. 1st ed", pp.279~284 (1999), Isis Medical Media
- Schaeffer AJ, "NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis", Int J Antimicrob Agents, 24, pp.49~52 (2004)
- Millán-Rodríguez F, "Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract", World J Urol, 24, pp.45~50 (2006)